Taken together, our analysis of the TCGA human ccRCC data is consistent with the activation of the mtDNA-cGAS-STING pathway in these patients, the majority of whom have VHL deficiencies. The gene discussed is STING1; the disease is nonpapillary renal cell carcinoma.